The Muscle-Brain Axis and Neuroprotection

Recent research highlights the muscle-brain axis as a vital link in cognitive health. Exercise-induced myokines are signaling molecules released by skeletal muscles during physical activity. These proteins serve as critical messengers that facilitate communication between peripheral tissues and the central nervous system. Consequently, they trigger neuroprotective pathways that may slow the progression of Alzheimer’s disease (AD). Epidemiological data indicates that consistent physical exercise can reduce the risk of AD by 30% to 45%. However, the precise molecular mechanisms behind this protection remain a subject of intense study.

Mechanisms of Exercise-Induced Myokines

Preclinical studies demonstrate that exercise-induced myokines modulate AD pathology through three primary pathways. Firstly, they facilitate the clearance of amyloid-beta and tau proteins. For example, the myokine Irisin increases the expression of neprilysin, an enzyme that degrades toxic amyloid plaques. Secondly, these molecules suppress neuroinflammation by shifting microglia toward an anti-inflammatory phenotype. Furthermore, they enhance synaptic plasticity and hippocampal neurogenesis. These processes are essential for maintaining cognitive function and memory. While human data show some variability based on APOE genotype and age, the overall evidence supports the therapeutic potential of the muscle secretome.

Translational Barriers and Future Directions

Despite promising findings, several hurdles limit the clinical application of myokine therapy. Ensuring effective delivery across the blood-brain barrier remains a significant technical challenge. Moreover, the pleiotropic nature of molecules like Interleukin-6 (IL-6) poses risks, as they may act as neuroprotective in acute settings but harmful during chronic inflammation. Emerging research focuses on innovative solutions like exercise mimetics and nanocarrier systems to bypass these obstacles. However, these combinatorial approaches are currently speculative and require rigorous clinical validation before implementation in standard care. Scientists suggest that future trials must prioritize mechanistic rigor and standardized biomarker validation to address patient heterogeneity.

FAQ

Which specific exercise-induced myokines are most beneficial for the brain?

Irisin, Brain-Derived Neurotrophic Factor (BDNF), and Cathepsin B are the primary myokines identified for their neuroprotective effects. They help in reducing toxic protein buildup and supporting neuronal health.

How does physical activity reduce the risk of Alzheimer’s disease?

Physical activity stimulates the release of exercise-induced myokines, which reduce neuroinflammation, enhance synaptic plasticity, and promote the clearance of harmful amyloid-beta plaques.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Shirvani H et al. Unlocking Neuroprotection: Exercise-Induced Muscle Secretome (Myokines) as a Therapeutic Avenue Against Alzheimer's Disease Pathogenesis. J Mol Neurosci. 2026 Jun 10. doi: undefined. PMID: 42268366.

Lourenco MV, et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s disease models. Nat Med. 2019;25(1):165-175.

Kim E, Tanzi RE, Choi SH. Therapeutic potential of exercise-hormone irisin in Alzheimer's disease. Neural Regen Res. 2025;20(6):1555-1564.